Wednesday 24th March 2021
|Text too small?|
Oceania Healthcare Limited is pleased to announce that it has successfully completed the bookbuild for the NZ$80 million institutional placement component (Placement) of the NZ$100 million equity raising announced on 23 March 2021. The Placement was strongly supported by existing institutional shareholders and also attracted significant bids from other institutional investors.
The Placement was fully subscribed at the fixed price of NZ$1.30 per share. This price represents a discount of 6.5% to the last close price of NZ$1.39 per share on 22 March 2021 and a discount of 8.1% to the 5-day VWAP of NZ$1.41 (up to and including 22 March 2021).
Oceania undertook the Placement with the key objectives of treating all shareholders fairly and prioritising existing shareholders. All existing eligible institutional shareholders who bid for their pro-rata allocation of the Placement were allocated at least that amount of new shares.
As announced on 23 March 2021, Oceania is also undertaking a non-underwritten NZ$20 million retail offer (with the ability to accept oversubscriptions at Oceania’s discretion) (Retail Offer). A Retail Offer document, together with an application form, will be sent to eligible New Zealand resident shareholders on 25 March 2021 and will also be available at www.shareoffer.co.nz/oceaniahealthcare from that date. All eligible shareholders are encouraged to visit that website and apply online.
Please see the link below for details:
No comments yet
Napier Port Holdings Limited (NZX: NPH) 2021 Earnings Guidance Update
Comvita Limited (NZX: CVT) Full Year Guidance Update
Scott Technology Limited (NZX: SCT) Meat Industry Contract Win
PaySauce Limited (NZX: PYS) Quarterly Market Update
NZ Windfarms Limited (NZX: NWF) Agrees a New VVFPA for Q1 2022 to Q3 2022
Harmoney Corp Limited (NZX: HMY) 3Q21 Trading Update
Pacific Edge Limited (NZX: PEB) United Healthcare Issues Positive Coverage Cxbladder
Scott Technology Limited (NZX: SCT) 2021 Half Year Announcement
NZX Limited (NZX: NZX) Appoints Specialist Global Expert to Tech Committee
AFT Pharmaceuticals Limited (NZX: AFT) Secures New Partners in Poland and Greece